RMDN3 Antibodies are employed to study RMDN3’s roles in cellular processes, including:
RMDN3 interacts with VAPB (VAMP-associated protein B) at ER-mitochondria contact sites (MERCs) to mediate lipid radical transfer under oxidative stress. Knockdown studies using RMDN3 antibodies confirmed that this interaction is critical for scavenging mitochondrial lipid radicals, thereby preventing cell death .
RMDN3 regulates apoptosis via interactions with microtubules and calcium signaling pathways. Overexpression of RMDN3 induces apoptosis, a process that can be studied using antibodies to track protein localization and activity .
RMDN3 is implicated in carcinomas (e.g., prostate, squamous cell) and benign hyperplasia. Antibodies enable detection of RMDN3 expression in tumor tissues, aiding in understanding its role in disease progression .
Specificity: Polyclonal antibodies may bind non-specific epitopes; validation via immunoprecipitation or immunoblotting is essential.
Cross-reactivity: Mouse and rat homologs share 80–84% sequence identity with human RMDN3 .
Applications: Optimal for studying RMDN3 in cellular models but not validated for diagnostic use .